| Date Filed | Type | Description |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| ACKERMANN CHRISTINA (Please see remarks) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| ACKERMANN CHRISTINA (Please see remarks) has filed a Form 4 on Bausch & Lomb Corp|
Txns:
| Granted 83,333 shares
@ $0
Granted 329,670 options to buy
@ $18, valued at
$5.9M
|
|
| 05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| ACKERMANN CHRISTINA (Director) has filed a Form 3 on GRAYBUG VISION, INC. |
| 08/31/2020 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Granted 28,171 shares
@ $0 |
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 3,360 shares
@ $29.42, valued at
$98.9k
|
|
| 08/13/2019 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 7,779 shares
@ $22.39, valued at
$174.2k
Sold 3,418 shares
@ $22.4475, valued at
$76.7k
|
|
| 07/15/2019 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Sold 3,968 shares
@ $24.81, valued at
$98.4k
|
|
| 03/12/2019 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 3,630 shares
@ $23.56, valued at
$85.5k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2019 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 3,446 shares
@ $21.25, valued at
$73.2k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2018 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Bausch Health Companies Inc.|
Txns:
| Paid exercise price by delivering 7,779 shares
@ $23.52, valued at
$183k
|
|
| 03/09/2018 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Granted 20,457 shares
@ $0
Granted 60,853 options to buy
@ $15.32, valued at
$932.3k
Granted 13,638 options to buy
@ $0 |
|
| 01/09/2018 |
4
| ACKERMANN CHRISTINA (EVP AND GENERAL COUNSEL) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.|
Txns:
| Paid exercise price by delivering 3,649 shares
@ $23.85, valued at
$87k
|
|
| 08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|